Sandoz

Entity type image
Type: Company
Name: Sandoz
First reported 4 hours ago - Updated 1 hour ago - 2 reports

FDA approves first generic Atacand

Sandoz has become the first company to gain the FDA approval to produce a generic version of Atacand (candesartan cilexetil), the popular heart drug that generated an estimated 120 million in domestic sales last year.“Sandoz is proud to be the first generic ... [Published Drugtopics.com - 1 hour ago]
First reported 4 hours ago - Updated 4 hours ago - 1 reports

Sandoz recalls injectable methotrexate

Sandoz is conducting a voluntary nationwide recall at the U.S. hospital/user level of two lots of its injectable methotrexate sodium, USP, 25 mg/mL, 40 mL vials, as a result of the discovery of particulate matter during routine quality examination of ... [Published Drugtopics.com - 4 hours ago]
First reported 6 hours ago - Updated 5 hours ago - 2 reports

Momenta Pharmaceuticals Management Presents at 2013 UBS Global Healthcare Conference (Transcript)

Momenta Pharmaceuticals, Inc. (MNTA) UBS Global Healthcare Conference Call May 21, 2013 11:00 AM ETAmi Fadia – UBSThanks for joining us. I’m Ami Fadia, I cover spec pharma stocks at UBS and it's my pleasure to have Rick Shea, the Chief Financial Officer ... [Published Seeking Alpha - 5 hours ago]
First reported 7 hours ago - Updated 7 hours ago - 1 reports

FDA approves Sandoz hypertension drug

Alaric DeArmentThe Food and Drug Administration has approved a generic heart disease drug made by Sandoz, the company said.read more ... [Published Drug Store News - 7 hours ago]
First reported 9 hours ago - Updated 8 hours ago - 1 reports

Deadly Drug Trials: Western Firms Bribed East German Doctors

It wasn't just the East German government that benefited from risky patient drug trials commissioned by Western pharmaceutical manufacturers decades ago. These companies also sent liaisons with lavish gifts to bribe and influence doctors to participa ... [Published Spiegel Online - 9 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

Report Previews Future of U.S. Biosimilar Market

The IP & Science business of Thomson Reuters released a life sciences report, “An Outlook on U.S. Biosimilar Competition,” which provides a view of the challenges facing companies entering the United States biosimilar drug market and key players predicted ... [Published Pharmaceutical Technology - 21 hours ago]
First reported May 20 2013 - Updated May 21 2013 - 6 reports

Methotrexate Sodium Injectable Vials Recall

5/21/2013Sandoz is conducting a voluntary nationwide recall to the hospital/user level of 2 lots (CL0996, expiration December 2013; CJ4948, expiration May 2013) of its methotrexate sodium 25 mg/mL, 40 mL injectable vials because of the discovery of particulate ... [Published Facts & Comparisons - May 21 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

CANDESARTAN CILEXETILtablet [Sandoz Inc]

Entities: Candesartan, Sandoz
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Losses fall for Vectura

Respiratory products developer Vectura has reported a reduction in its pre-tax losses in a "significant" year for the business.The Chippenham-based company has posted a pre-tax loss of 10.4m for the year to 31 March 2013 down from 13.2m in the previous ... [Published Insider Media Limited - May 21 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Pie Face

There was a lot of pie smearing at Sandoz Elementary School in Lexington this afternoon Monday.     And it was all to celebrate the schools' accomplishment for exceeding their reading goal.     Teachers challenged their students at the beginning of the ... [Published KNOP-TV - May 21 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports

Sandoz launches allergy rhinitis drug in Slovenia

Sandoz, a generic pharmaceuticals division of Novartis, has launched a generic mometasone nasal spray for the treatment of seasonal or perennial allergy rhinitis and symptomatic treatment of nasal polyps in Slovenia. Mometasone nasal spray has already ... [Published Individual.com - May 20 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports

The Top 3 Companies Set to Dominate US Biosimilar Market

Biosimilars – products that are “highly similar” to an already-approved biological product – are on the rise in the US, although the country still lags behind other nations in the biosimilar space.  A new report from Thomson Reuters, ‘ An Outlook on US ... [Published Terrapinn - May 20 2013]

Quotes

According to the reports, the Bayer employee advised his managers to continue with the "old approach." To be able to do so, he requested "the transfer of a sum of money to the relevant GDR scientists." Now, decades later, money is at issue once again, but this time it is a matter of who will pay for the investigation of the scandal...
Carl-Ãke Carlsson, Chief Executive and President, said: "3iâs investment and continued support, expertise and commitment has enabled Xellia to successfully grow and transition the business to become leaders in the supply of key anti-infective products. Now, as we focus on the future and the further development of the business, including the launch of our novel antibiotics pipeline, we look forward to working with Novo and benefitting from their immense experience in the life sciences sector.â"
The FDA cautioned that parenteral injection of the drug from the affected lots (25 mg/mL, 40 mL) "can lead to microembolisation in areas where the particles lodge." The agency said it was unlikely that clinical symptoms would arise from those microemboli and said that drugmaker Sandoz is "not aware of any reports...
Tomas Ekman, 3i Managing Director and Partner, commented: "Over the last five years, the 3i team has worked closely with Xellia's excellent management team to build the Company into a market leader and create a well-diversified product portfolio. It has been a fantastic experience to work with Carl-$ke Carlsson and the management team." Carl-$ke Carlsson, Chief Executive and President, said: "3i's investment and continued support, expertise and commitment has enabled Xellia to successfully...

More Content

All (390) | News (247) | Reports (15) | Blogs (108) | Audio/Video (0) | Fact Sheets (8) | Press Releases (12)
sort by: Date | Relevance
FDA approves first generic Atacand [Published Drugtopics.com - 1 hour ago]
Sandoz recalls injectable methotrexate [Published Drugtopics.com - 4 hours ago]
Par ships authorized generic cardiovascular drug [Published Drug Store News - 4 hours ago]
Momenta Pharmaceuticals Management Presents at ... [Published Seeking Alpha - 5 hours ago]
Why Momenta Offers A Unique Opportunity In The ... [Published Seeking Alpha - 6 hours ago]
FDA approves Sandoz hypertension drug [Published Drug Store News - 7 hours ago]
Deadly Drug Trials: Western Firms Bribed East G... [Published Spiegel Online - 9 hours ago]
3i makes a 2.3x return on sale of Xellia [Published India Infoline - 18 hours ago]
Report Previews Future of U.S. Biosimilar Market [Published Pharmaceutical Technology - 21 hours ago]
Tweets of the day, 5/21/2013 [Published Pharma Live - May 21 2013]
Methotrexate Sodium Injectable Vials Recall [Published Facts & Comparisons - May 21 2013]
CANDESARTAN CILEXETILtablet [Sandoz Inc] [Published DailyMed Drug Label Updates for the last seven ... - May 21 2013]
Vectura Group plc (VEC.L) Board Change [Published BioSpace - May 21 2013]
FDA, Sandoz recall methotrexate [Published Dermatology Times - May 21 2013]
FDA: Injectable Methotrexate Recalled [Published MedPage Today - May 21 2013]
Novo Acquires Anti-Infective Developer Xellia f... [Published Genetic Engineering News - May 21 2013]
Methotrexate Sodium, USP Injectable Vials by Sa... [Published U.S. Food and Drug Administration - May 21 2013]
Vectura Group plc – Preliminary Results for the... [Published Vectura Group - May 21 2013]
3i makes a 2.3x return on the sale of Xellia [Published Noodls - May 21 2013]
Losses fall for Vectura [Published Insider Media Limited - May 21 2013]
Pie Face [Published KNOP-TV - May 21 2013]
Sandoz recalls Methotrexate Sodium injectable v... [Published PBR - News - May 21 2013]
Sandoz US Announces Voluntary Nationwide Recall... [Published U.S. Food and Drug Administration - May 20 2013]
Court Report -- May 19, 2013 [Published JD Supra - May 20 2013]
Women want Apotex to pay for unwanted pregnancies [Published FiercePharma - May 20 2013]
New Report Available: Novartis AG (NOVN) - Fina... [Published Live-PR.com - May 20 2013]
Sandoz launches allergy rhinitis drug in Slovenia [Published Individual.com - May 20 2013]
The Top 3 Companies Set to Dominate US Biosimil... [Published Terrapinn - May 20 2013]
Therapeutic Class Report Overview - Japan Biosi... [Published TransWorldNews - May 20 2013]
Sandoz Inc. - Pharmaceuticals & Healthcare - De... [Published TransWorldNews - May 18 2013]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
CANDESARTAN CILEXETILtablet [Sandoz Inc] [Published DailyMed Drug Label Updates for the last seven ... - May 21 2013]
Updated Date: May 21, 2013 EST ...
Sandoz recalls Methotrexate Sodium injectable v... [Published PBR - News - May 21 2013]
Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US. ...
AZITHROMYCINtablet, Film Coated [Sandoz Inc] [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
Updated Date: May 13, 2013 EST ...
RIBAVIRINcapsule [Sandoz Inc] [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
Updated Date: May 13, 2013 EST ...
AMOXICILLIN AND CLAVULANATE POTASSIUMtablet, Fi... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
Updated Date: May 10, 2013 EST ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Amgen, Hospira and Sandoz Named Among Top Pharm... [Published Financial Services - May 14 2013]
Health Robotics Appoints Gordon Meyer to Board ... [Published PR Newswire: Health - May 01 2013]
Janus Resources Announces Appointment of Dr. Ke... [Published EON Business - Mar 13 2013]
Janus Resources Announces Appointment of Dr. Ke... [Published Business Wire Photo/Multimedia News - Mar 13 2013]
Janus Resources Announces Appointment of Dr. Ke... [Published Business Wire Natural Resources News - Mar 13 2013]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.